IDXX
IDEXX Laboratories, Inc. · Healthcare · Diagnostics & Research
TECHSellZACKSHold
R500#271 today
$518.39
+0.12% today · -0.17% 1W
Oct 2 close or latest
PreviewWhy it's moving
Moving with the market
- IDXX +0.12% on the last session vs SPY +0.74%: −0.6 pts of stock-specific move.
- Aftermath, big drop (Sep 30): After its 58 big drops in the past 5 years, IDXX typically gained 1.4% over the next month (median) and was higher 59% of the time; half the outcomes fell between -3.7% and +4.8%. An ordinary month: -0.8%. Among S&P 500 stocks after big drops, that ranks #280 of 500.
- Market backdrop (Fri): Average Hourly Earnings m/m 0.1% vs 0.3% expected (cooler); Non-Farm Employment Change 29K vs 89K expected (weaker); S&P futures +0.41%, 10-year yield -5bp in the 30 minutes after.
Assembled from Wallsti's own signals.
Next report
Nov 2
Before the open · in 29 days
EPS estimate
$3.70
$3.37 to $3.91 · 11 analysts
Revenue estimate
$1.2B
$1.2B to $1.2B
Track record
8/8 beats
last 8 reports · moved ±10.0% on average
Reports
| Reported | Quarter | EPS est. | EPS | EPS surprise | Revenue | Reaction | Gap | 5 days |
|---|---|---|---|---|---|---|---|---|
| Aug 4, 2026 BMO | 2Q2026 | $3.93 | $4.27 | +$0.34 (+8.5%) beat | $1.2B | +3.6% +1.8 vs SPY | +6.1% | +4.9% |
| May 5, 2026 BMO | 1Q2026 | $3.41 | $3.47 | +$0.06 (+1.7%) beat | $1.1B | 0.0% -0.8 vs SPY | +1.1% | -5.5% |
| Feb 2, 2026 BMO | 4Q2025 | $2.94 | $3.08 | +$0.14 (+4.8%) beat | $1.1B | -4.6% -5.1 vs SPY | -2.0% | -3.9% |
| Nov 3, 2025 BMO | 3Q2025 | $3.15 | $3.40 | +$0.25 (+8.1%) beat | $1.1B | +14.8% +14.7 vs SPY | +10.1% | +12.5% |
| Aug 4, 2025 BMO | $3.30 | $3.63 | +$0.33 (+10.0%) beat | — | +27.5% +26.0 vs SPY | +23.7% | +22.9% | |
| May 1, 2025 BMO | $2.84 | $2.96 | +$0.12 (+4.2%) beat | — | +8.9% +8.2 vs SPY | +8.2% | +12.5% | |
| Feb 3, 2025 BMO | $2.40 | $2.62 | +$0.22 (+9.2%) beat | — | +11.1% +11.8 vs SPY | +10.2% | +8.9% | |
| Oct 31, 2024 BMO | $2.69 | $2.80 | +$0.11 (+4.1%) beat | — | -9.8% -7.8 vs SPY | -4.7% | -6.1% | |
| Aug 6, 2024 BMO | $2.87 | $3.02 | +$0.15 (+5.2%) beat | — | +3.1% +2.2 vs SPY | +2.2% | +5.5% | |
| May 1, 2024 BMO | $2.68 | $2.81 | +$0.13 (+4.9%) beat | — | -5.0% -4.7 vs SPY | -4.0% | -1.8% | |
| Feb 5, 2024 BMO | $2.12 | $2.32 | +$0.20 (+9.4%) beat | — | +8.5% +8.9 vs SPY | +0.8% | +8.6% | |
| Nov 1, 2023 BMO | $2.37 | $2.53 | +$0.16 (+6.8%) beat | — | -1.0% -2.1 vs SPY | -2.8% | +5.8% | |
| Aug 1, 2023 BMO | $2.47 | $2.67 | +$0.20 (+8.1%) beat | — | -4.0% -3.8 vs SPY | -3.6% | -8.4% | |
| May 2, 2023 BMO | $2.43 | $2.55 | +$0.12 (+4.9%) beat | — | -4.5% -3.4 vs SPY | -1.8% | -0.8% | |
| Feb 6, 2023 BMO | $1.92 | $2.05 | +$0.13 (+6.8%) beat | — | +0.7% +1.3 vs SPY | +1.8% | +0.7% | |
| Nov 1, 2022 BMO | $2.04 | $2.15 | +$0.11 (+5.4%) beat | — | +9.8% +10.2 vs SPY | +4.3% | +7.1% | |
| Aug 2, 2022 BMO | $1.63 | $1.56 | −$0.07 (−4.3%) miss | — | +0.2% +0.9 vs SPY | -2.0% | +2.2% | |
| May 4, 2022 BMO | $2.25 | $2.27 | +$0.02 (+0.9%) beat | — | -5.7% -8.7 vs SPY | -12.4% | -22.0% | |
| Feb 2, 2022 BMO | $1.72 | $1.89 | +$0.17 (+9.9%) beat | — | +4.0% +3.1 vs SPY | +4.8% | +1.6% | |
| Nov 2, 2021 BMO | $1.91 | $2.03 | +$0.12 (+6.3%) beat | — | -5.9% -6.3 vs SPY | -1.8% | -4.8% | |
| Jul 30, 2021 BMO | $2.04 | $2.34 | +$0.30 (+14.7%) beat | — | — | — | — | |
| May 4, 2021 BMO | $1.72 | $2.35 | +$0.63 (+36.6%) beat | — | — | — | — | |
| Feb 2, 2021 BMO | $1.39 | $1.76 | +$0.37 (+26.6%) beat | — | — | — | — | |
| Oct 29, 2020 BMO | $1.44 | $1.69 | +$0.25 (+17.4%) beat | — | — | — | — |
BMO = before the open, AMC = after the close. Reaction: the first session that could trade on the report (the same day for BMO, the next session for AMC) against the close before it; "vs SPY" subtracts the S&P 500 over the same session. EPS surprise is in dollars, with the percentage only when the estimate is at least $0.10 (near zero, a small beat would show as hundreds of percent). Revenue surprise needs the estimate from before the report, so it starts with the reports Wallsti saw coming.
Analyst estimates
| Period | EPS | Range | vs year ago | 90-day trend | Revisions 30d | Revenue | vs year ago |
|---|---|---|---|---|---|---|---|
| Current quarter · Sep 30, 2026 | $3.70 (11) | $3.37 – $3.91 | +9% | -2.1% | ▲3 ▼7 | $1.2B | +8% |
| Next quarter · Dec 31, 2026 | $3.36 (10) | $3.09 – $3.55 | +9% | -2.6% | ▲1 ▼8 | $1.2B | +8% |
| Current year · Dec 31, 2026 | $14.83 (12) | $14.46 – $15.18 | +13% | +1.1% | ▲11 ▼0 | $4.7B | +10% |
| Next year · Dec 31, 2027 | $16.74 (12) | $16.07 – $17.13 | +13% | +1.3% | ▲11 ▼2 | $5.1B | +9% |
Consensus as of Oct 4, 2026. Source: Yahoo Finance analyst estimates; schedule and timing also from Nasdaq's earnings calendar.